BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 23692645)

  • 1. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    Gathier CS; van den Bergh WM; van der Jagt M; Verweij BH; Dankbaar JW; Müller MC; Oldenbeuving AW; Rinkel GJE; Slooter AJC;
    Stroke; 2018 Jan; 49(1):76-83. PubMed ID: 29158449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Induced Hypertension on Cerebral Perfusion in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    Gathier CS; Dankbaar JW; van der Jagt M; Verweij BH; Oldenbeuving AW; Rinkel GJ; van den Bergh WM; Slooter AJ;
    Stroke; 2015 Nov; 46(11):3277-81. PubMed ID: 26443829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.
    Wong GK; Liang M; Tan H; Lee MW; Po YC; Chan KY; Poon WS
    Neurosurgery; 2013 May; 72(5):840-4. PubMed ID: 23392270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Perfusion Pressure and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Yousef KM; Balzer JR; Bender CM; Hoffman LA; Poloyac SM; Ye F; Sherwood PR
    Am J Crit Care; 2015 Jul; 24(4):e65-71. PubMed ID: 26134341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).
    Leijenaar JF; Dorhout Mees SM; Algra A; van den Bergh WM; Rinkel GJ;
    Int J Stroke; 2015 Oct; 10 Suppl A100():108-12. PubMed ID: 26502971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm.
    Yoneda H; Nakamura T; Shirao S; Tanaka N; Ishihara H; Suehiro E; Koizumi H; Isotani E; Suzuki M;
    Stroke; 2013 Aug; 44(8):2155-61. PubMed ID: 23735953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.
    Ma C; Zhou W; Yan Z; Qu M; Bu X
    J Neurol Sci; 2015 Dec; 359(1-2):67-71. PubMed ID: 26671088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostacyclin on cerebral blood flow and vasospasm after subarachnoid hemorrhage: randomized, pilot trial.
    Rasmussen R; Wetterslev J; Stavngaard T; Juhler M; Skjøth-Rasmussen J; Grände PO; Olsen NV
    Stroke; 2015 Jan; 46(1):37-41. PubMed ID: 25414173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
    Haegens NM; Gathier CS; Horn J; Coert BA; Verbaan D; van den Bergh WM
    Stroke; 2018 Nov; 49(11):2630-2636. PubMed ID: 30355184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage?
    Westermaier T; Stetter C; Kunze E; Willner N; Holzmeier J; Kilgenstein C; Lee JY; Ernestus RI; Roewer N; Muellenbach RM
    J Neurosurg; 2014 Nov; 121(5):1056-62. PubMed ID: 25148012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
    Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
    Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository.
    Jaja BN; Lingsma H; Schweizer TA; Thorpe KE; Steyerberg EW; Macdonald RL;
    J Neurosurg; 2015 Mar; 122(3):644-52. PubMed ID: 25554825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Lund concept versus cerebral perfusion pressure-targeted therapy: a randomised controlled study in patients with secondary brain ischaemia.
    Dizdarevic K; Hamdan A; Omerhodzic I; Kominlija-Smajic E
    Clin Neurol Neurosurg; 2012 Feb; 114(2):142-8. PubMed ID: 22036839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis.
    Wong GK; Wong A; Zee BC; Poon WS; Chan MT; Gin T; Siu DY; Mok VC
    J Neurol Sci; 2015 Nov; 358(1-2):58-61. PubMed ID: 26285662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage.
    Mutoh T; Kazumata K; Terasaka S; Taki Y; Suzuki A; Ishikawa T
    Stroke; 2014 May; 45(5):1280-4. PubMed ID: 24692480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.